前收市價 | 26.18 |
開市 | 26.06 |
買盤 | 25.76 x 100 |
賣出價 | 25.82 x 200 |
今日波幅 | 25.62 - 26.06 |
52 週波幅 | 25.00 - 34.53 |
成交量 | |
平均成交量 | 760,638 |
市值 | 2.311B |
Beta 值 (5 年,每月) | 1.05 |
市盈率 (最近 12 個月) | 12.71 |
每股盈利 (最近 12 個月) | 2.03 |
業績公佈日 | 2024年6月19日 - 2024年6月24日 |
遠期股息及收益率 | 1.04 (4.03%) |
除息日 | 2024年4月18日 |
1 年預測目標價 | 29.80 |
With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and services. It’s one of the essentials of life, which makes the industry such a politically sensitive matter. Besides the critical need, another element that helps bolster the case for healthcare stocks is the underlying diversity. Yes, the sector centers on the pharmaceutical innovation space. However,
With the market trading near all-time highs, undervalued healthcare stocks offer a compelling opportunity. Fundamentally, the sector could benefit from a rotation in the innovation ecosystem. As a Reuters report mentioned recently, publicly traded technology enterprises witnessed a huge outflow of $4.4 billion. In fact, it was the largest-ever outflow of funds over a single week. It’s not hard to understand why. As artificial intelligence and other technologies boosted share prices, it makes sen
Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.